HOSOYA Ken-ichi

J-GLOBAL         Last updated: Aug 30, 2018 at 18:29
 
Avatar
Name
HOSOYA Ken-ichi
Affiliation
University of Toyama
Section
Faculty of Pharmacy and Pharmaceutical Sciences, School of Pharmacy
Degree
(BLANK), Ph.D.

Research Areas

 
 

Academic & Professional Experience

 
Apr 2006
 - 
Today
Professor, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama
 
Oct 2013
 - 
Mar 2018
Dean, Faculty of Pharmaceutical Sciences, University of Toyama
 
Oct 2009
 - 
Sep 2013
Associate Dean, Faculty of Pharmaceutical Sciences, University of Toyama
 
Oct 2005
 - 
Mar 2006
Professor, Faculty of Pharmaceutical Sciences, University of Toyama
 
Oct 2000
 - 
Sep 2005
Professor, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University
 

Education

 
Apr 1983
 - 
Mar 1985
Graduate School of Pharmaceutical Sciences, Josai University
 
Apr 1979
 - 
Mar 1983
Pharmacy, Faculty of Pharmaceutical Sciences, Josai University
 

Awards & Honors

 
Nov 2009
Fellow, American Association of Pharmaceutical Scientists
 

Published Papers

 
Tachikawa M, Toki H, Watanabe M, Tomi M, Hosoya KI, Terasaki T
Anatomical science international   93(4) 456-463   Sep 2018   [Refereed]
Kinoshita Y, Nogami K, Jomura R, Akanuma SI, Abe H, Inouye M, Kubo Y, Hosoya KI
Molecular pharmaceutics   15(8) 3583-3594   Aug 2018   [Refereed]
Akanuma SI, Yamakoshi A, Sugouchi T, Kubo Y, Hartz AMS, Bauer B, Hosoya KI
Molecular pharmaceutics   15(6) 2327-2337   Jun 2018   [Refereed]
Kubo Y, Akanuma SI, Hosoya KI
Expert opinion on drug metabolism & toxicology   14(5) 513-531   May 2018   [Refereed]
Tachikawa M, Hirose S, Akanuma SI, Matsuyama R, Hosoya KI
Microvascular research   117 16-21   May 2018   [Refereed]
Kubo Y, Nakazawa A, Akanuma SI, Hosoya KI
Pharmaceutical research   35(5) 93   Mar 2018   [Refereed]
Akanuma SI, Higashi H, Maruyama S, Murakami K, Tachikawa M, Kubo Y, Hosoya KI
Experimental eye research   168 128-137   Mar 2018   [Refereed]
Tachikawa M, Watanabe M, Fukaya M, Sakai K, Terasaki T, Hosoya KI
Neurochemical research   43(2) 500-510   Feb 2018   [Refereed]
Tachikawa M, Yashiki A, Akanuma SI, Matsukawa H, Ide S, Minami M, Hosoya KI
Neurochemistry international   113 1-7   Feb 2018   [Refereed]
Akanuma SI, Yamazaki Y, Kubo Y, Hosoya KI
Fluids and barriers of the CNS   15(1) 1   Jan 2018   [Refereed]

Misc

 
YOICHI ADACHI, KEN-ICHI HOSOYA, KENJI SUGIBAYASHI, YASUNORI MORIMOTO
Chem. Pharm. Bull.   36(9) 3702-3705   1988
Effect of Azone concentration and solvents on the skin permeation of 5-fluorouracil and indomethacin,
Yakuzaigaku   51 80-86   1991
J. Pharm. Sci.   81(1) 58-64   1992
Kenichi HOSOYA, Hiroyuki KUBO, Hideshi NATSUME, Kenji SUGIBAYASHI, Yasunori MORIMOTO
Biol. Pharm. Bull.   17(2) 316-322   1994
Design and evaluation of sustained-release granules of sodium valproate
Yakuzaigaku   54 49-54   1994
Pharmacokinetics of valproic acid after oral administration of sustained-release granules of sodium valproate in human
Yakuzaigaku   54 55-60   1994
Contribution of Na+-glucose cotransport to the short-circuit current in th e pigmented rabbit conjunctiva
Curr. Eye Res.   15 447-451   1996
Curr. Eye Res.   16 693-697   1997
Nucleoside transport mechanisms in the pigmented rabbit conjunctiva
Invest. Ophthalmol. Vis. Sci.   39 372-377   1998
Carrier-mediated transport of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, in the pigmented rabbit conjunctiva
J. Pharmacol. Exp. Ther.   285 223-227   1998
Carrier-mediated transport of monocarboxylate transport in the pigmented rabbit conjunctiva
Invest. Ophthalmol. Vis. Sci.   39 1436-1443   1998
Nucleotide stimulation of net Cl- secretion in the rabbit conjunctiva
J. Pharmacol. Exp. Ther.   291 53-59   1999
mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines ; a new in vitro BBB model for drug targeting
J Drug Targeting   8(357-370)    2000
Conditionally immortalized brain capillary endothelial cell lines established from transgenic mouse harboring temperature-sensitive SV 40 large T-antigen gene
AAPS Pharm Sci.(http : //www.pharmsci.org)   2(Article 27)    2000
GAT2/BGT-1 as a system responsible for the transport of g-aminobutyric acid at the mouse blood-brain barrier
J. Cereb. Blood Flow Metab.   21, 1232-1239    2001
Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-b1 and b-glycerophosphate
Eur. J. Cell Biol.   81, 145-152    2002
Induction of the xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier
Invest. Ophthalmol. Vis. Sci.   43, 774-779    2002
The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the bra
J. Cereb. Blood Flow Metab.   22, 1327-1335    2002

Books etc

 
Drug delivery to the posterior segment. IN Retina, 3rd Edition
Mosby, St. Louis   2001   
Brain barrier function : its analysis and reconstitution. IN Tissue Engineering for Therapeutic Use 4
Elsevier, Amsterdam   2000   
The brain efflux index method(BEI). IN Brain barrier Systems, Alfred Benzon Symposium 45
Munksgaard, Copenhagen   1999   

Research Grants & Projects

 
Transport mechanism at the blood-retinal barrier